A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies Prosigna™ Gene Signature Assay

Study of Breast Tissue in Women Not Previously Diagnosed With Breast Cancer Who Are Undergoing Fine Needle Aspiration

NCT00896636 ·Status: UNKNOWN

Prospective Study of the Prosigna Assay on Neoadjuvant Clinical Decision-making in Women With HR+/Her2- Breast Cancer

NCT03749421 ·Status: ACTIVE_NOT_RECRUITING

Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer

NCT00897208 ·Status: COMPLETED

Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification

NCT01839045 ·Status: UNKNOWN

Clinical Evaluation of OSNA Breast Cancer System in Breast Cancer Patients Receiving Neoadjuvant Therapy

NCT01140776 ·Status: TERMINATED

Evaluating Whether Integration of Prognostic and Predictive Algorithms Into Routine Clinical Practice Effect Whether Oncologists Order Multigene Assays in Patients With Early Stage Breast Cancer

NCT04131933 ·Status: COMPLETED

Genomic Signatures to Predict Treatment Response

NCT02032745 ·Status: COMPLETED

Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol

NCT02078570 ·Status: UNKNOWN

Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior

NCT01000883 ·Status: RECRUITING

Peptide Profiles of Women Undergoing Breast Biopsy

NCT00587821 ·Status: COMPLETED

Identification of Biomarkers in Women at High Risk or Average Risk of Breast Cancer

NCT00897416 ·Status: COMPLETED

Identification of New Prognostic Markers for Breast Cancer.

NCT03436069 ·Status: RECRUITING

PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST

NCT06979921 ·Status: ACTIVE_NOT_RECRUITING

Clinical Evaluation of OSNA Breast Cancer System to Extensive Frozen Section Histopathology

NCT01368744 ·Status: COMPLETED

Early Detection of Breast Cancer

NCT06043661 ·Status: RECRUITING

Multidisciplinary Approach to Breast Cancer Through the Study of Altered Transcriptomic and Immune Accompanied by the Identification of Extractable Markers From the Radiodiagnostic Bioimaging

NCT05809128 ·Status: UNKNOWN

Utilization of Genomic Signature as Decision-making for Adjuvant Treatment of Breast Cancer

NCT00912080 ·Status: UNKNOWN ·Phase: NA

A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer

NCT01423890 ·Status: COMPLETED ·Phase: NA

Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer

NCT01007890 ·Status: TERMINATED

Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant Chemotherapy

NCT03709134 ·Status: COMPLETED

InheriteD brEast caNcer iTalian regIsTrY A Retrospective-prospective Observational Cohort Study to Evaluate Cancer Prevention Strategies in Women With a Deleterious Mutation in BRCA1-2

NCT05835739 ·Status: RECRUITING

Biomarkers in Native American Women With Breast Cancer

NCT00898976 ·Status: COMPLETED

Clinical Pilot Study for Personalized Risk-based Breast Cancer Screening

NCT05731453 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer

NCT00001496 ·Status: COMPLETED

Oncotype DX in BRCA-mutated Breast Cancer Patients: Our Experience. A Retrospective Observational Monocentric Study

NCT06484725 ·Status: COMPLETED